Literature DB >> 10329411

Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone.

G P Saborío1, C Soto, R J Kascsak, E Levy, R Kascsak, D A Harris, B Frangione.   

Abstract

A conformational transition between the normal cellular prion protein (PrPC) and the beta-sheet-rich pathological isoform (PrPSc) is a central event in the pathogenesis of spongiform encephalopathies. The prion infectious agent seems to contain mainly, if not exclusively, PrPSc, which has the ability to propagate its abnormal conformation by transforming the host PrPC into the pathological isoform. We have developed an in vitro system to induce the PrPC --> PrPSc conversion by incubating a cell-lysate containing mouse PrPC with partially purified mouse PrPSc. After 48 h of incubation with a 10-fold molar excess of PrPSc, the cellular protein acquired PK-resistance resembling a PrPSc-like state. Time course experiments suggest that the conversion follows a stepwise mechanism involving kinetic intermediates. The conversion was induced by PrPSc extracted from mice infected with two different prion strains, each propagating its characteristic Western blot profile. The latter results and the fact that all the cellular components are present in the conversion reaction suggest that PrPC-PrPSc interaction is highly specific and required for the conversion. No transformation was observed under the same conditions using purified proteins without cell-lysate. However, when PrPC-depleted cell-lysate was added to the purified proteins the conversion was recovered. These findings provide direct evidence for the participation of a chaperone-like activity involved in catalyzing the conversion of PrPC into PrPSc. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329411     DOI: 10.1006/bbrc.1999.0660

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Interaction of prion protein with small highly structured RNAs: detection and characterization of PrP-oligomers.

Authors:  Sara Vasan; Phyllus Y Mong; Abraham Grossman
Journal:  Neurochem Res       Date:  2006-06-02       Impact factor: 3.996

2.  RNA and CuCl2 induced conformational changes of the recombinant ovine prion protein.

Authors:  Meili Liu; Shan Yu; Jianmin Yang; Xiaomin Yin; Deming Zhao
Journal:  Mol Cell Biochem       Date:  2006-07-20       Impact factor: 3.396

3.  Formation of native prions from minimal components in vitro.

Authors:  Nathan R Deleault; Brent T Harris; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

4.  Selective incorporation of polyanionic molecules into hamster prions.

Authors:  James C Geoghegan; Pablo A Valdes; Nicholas R Orem; Nathan R Deleault; R Anthony Williamson; Brent T Harris; Surachai Supattapone
Journal:  J Biol Chem       Date:  2007-10-16       Impact factor: 5.157

5.  Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.

Authors:  Max Nunziante; Kerstin Ackermann; Kim Dietrich; Hanna Wolf; Lars Gädtke; Sabine Gilch; Ina Vorberg; Martin Groschup; Hermann M Schätzl
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

6.  Neurotoxic effect of the complex of the ovine prion protein (OvPrP(C)) and RNA on the cultured rat cortical neurons.

Authors:  Mei-Li Liu; Jian-Jun Wen; Xue-Fang Xu; De-Ming Zhao
Journal:  Neurochem Res       Date:  2011-05-24       Impact factor: 3.996

Review 7.  Phosphatidylethanolamine as a prion cofactor: potential implications for disease pathogenesis.

Authors:  Surachai Supattapone
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

8.  In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.

Authors:  Bonto Faburay; Dongseob Tark; Anumantha G Kanthasamy; Juergen A Richt
Journal:  Prion       Date:  2014       Impact factor: 3.931

9.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 10.  Cofactor molecules: Essential partners for infectious prions.

Authors:  Surachai Supattapone
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-24       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.